News | Proton Therapy | April 19, 2016

System combines isocentric cone beam CT and pencil beam scanning for ultra-fine proton therapy

April 19, 2016 — Texas Center for Proton Therapy and IBA (Ion Beam Applications S.A.) announced the first patient treated in North America with the 360-degree Proteus Plus gantry. The system provides a high-precision tandem of iscocentric cone beam computed tomography (CBCT) guidance and pencil beam scanning.

Pencil beam scanning radiates tumors with an ultra-fine proton beam that requires precise positioning of the patient to ensure treatment accuracy. IBA’s Proteus Plus 360-degree gantry allows the acquisition of CBCT volumetric imaging at isocenter to assure precise patient positioning that effectively leverages the power of pencil beam scanning to provide the most accurate proton therapy treatment available. This unique combination of technologies allows Texas Center for Proton Therapy to provide treatment for indications demanding the utmost precision.

The multi-room Proteus Plus installation at the Texas Center for Proton Therapy has been in clinical operation since November 2015.
Andrew K. Lee, M.D., M.P.H., medical director at Texas Center for Proton Therapy, commented, “The combination of volumetric CBCT image guidance and pencil beam scanning begins a new era in proton therapy. This will allow proton therapy to help a wider range of cancer patients while improving the treatment for currently treated indications. This vital technology will help fulfill our joint mission to protect, enhance, and save lives.”

For more information: www.iba-worldwide.com


Related Content

News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
arrow
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
News | Radiation Oncology

September 6, 2023 — Nina D’Abreo, MD, has been named as chief of the Division of Hematology and Medical Oncology at NYU ...

Time September 06, 2023
arrow
News | Radiation Oncology

August 30, 2023 — Elekta and the IAEA have signed a partnership agreement to jointly pursue common interests, including ...

Time August 30, 2023
arrow
News | Radiation Therapy

August 30, 2023 — A published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children ...

Time August 30, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 28, 2023 — TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK CEN and IBA, announced that ...

Time August 28, 2023
arrow
Subscribe Now